This is the first update to the original CTS communication distributed on July 6th. As previously communicated, all CTS healthcare partners will remain on the Grifols ZIKV clinical trial until at least the end of October 2018, which coincides with the end of the WNV season.
Check out the Communication page for the complete details on the NAT ZIKV test update or by clicking the link: Communications
As a service to our partners, CTS provides a copy of all licenses and accreditations on our website....
Reminder test emails for the Health and Human Services (HHS) email notifications for WNV reactives h...
Reminder - Five CTS Forms will be updated on Monday September 2, 2019. Some of the forms are posted ...
CTS successfully implemented Donor-Screen HLA® Class I and II testing on the Stratec Biomedical ...
On September 23, 2019, the new CTS Laboratory Information System successfully implemented in Da...
In 2016, the Procleix Panther instrument was introduced by Grifols in support of automated NAT ZIKA ...